This blog is intended as a current guide how to set about applying for a TGA GMP Manufacturing license for Medicinal Cannabis.
Process for applying for a TGA GMP Manufacturing Licence
Two Manufacturing Licences may be …
After a number of years pondering and specifying desiccant dehumidification methods in traditional pharmaceutical facilities, we believe that desiccant dehumidification in marijuana greenhouses should be more favourably considered.
In our previous experiences designing large marijuana …
Though the Medicinal Cannabis Industry in Australia is relatively green, across the pond in Canada and the US, the industry has been growing for some time. As with pharmaceutical facilities, designing and operating a …
Since 2006, PharmOut has been a leading provider of highly regarded and coveted Quality Management Systems (QMS) template packs. Purchasing is simple and facilitated through our online shop – a simple click here, pay …
Congratulations Colin Byrne
PharmOut is delighted to announce that Colin Byrne has been promoted to the role of Senior Consultant.
Colin has over 12 years of experience in the pharmaceutical industry, including more than 4 with …
It has been a big year for industry as organisations scramble to be in full compliance with PIC/S PE009-13. With the due date on January 1st 2019, this deadline is coming sooner than many …
One of the four approved pathways to supply Medicinal Cannabis in Australia is via Medicinal Cannabis Clinical Trails under the CTN scheme. This blog discusses this route in greater detail.
The use of Medicinal Cannabis …
For large Medicinal Cannabis greenhouses, you typically need a large flat area with a fall of less than 1 in 400 (making all airports prime Medicinal Cannabis cultivation sites). Recently, there was an article …
Finally that minor typo in Chapter 9 has been fixed; its been a frustrating 10 years! Now that’s off my chest, we can look at the main changes between PIC/S GMP PE 009 version …
Every year the TGA undertakes a comprehensive targeted consultation by engaging with peak therapeutic industry bodies in regard to the fees and charges proposal for the upcoming financial year.
The TGA is required to recover …
